Back to Search
Start Over
785O PIVOT IO 001: First disclosure of efficacy and safety of bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) vs NIVO monotherapy in advanced melanoma (MEL).
- Source :
-
Annals of Oncology . 2022 Supplement 7, Vol. 33, pS901-S901. 1p. - Publication Year :
- 2022
- Subjects :
- *NIVOLUMAB
*MELANOMA
*SAFETY
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159077702
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.911